Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | FPR3 | P25089 | 4/20 | 0.39 |
| ▸ | FPR2 | P25090 | 4/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | PLAT | P00750 | 1/20 | 0.36 |
| ▸ | POLR1A | O95602 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5654310 | 0.86 | KMT2A (0.62) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL9167791 | 0.78 | KMT2A (0.60) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL17428293 | 0.77 | KMT2A (0.58) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL363624 | 0.77 | KMT2A (0.56) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL166209 | 0.77 | KMT2A (0.56) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL13831072 | 0.76 | KMT2A (0.55) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL10018688 | 0.75 | KDM4E (0.58) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL4548019 | 0.75 | KMT2A (0.61) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL20852069 | 0.75 | KDM4E (0.58) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL20016690 | 0.75 | KMT2A (0.57) | KMT2ARAB9AALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222717-A1 | POLYMER AQUEOUS DISPERSION WITH CORE/SKIN STRUCTURE, METHOD FOR MAKING SAME AND APPLICATION THEREOF IN COATINGS | Cray Valley S.A. (FR) | 2010-09-01 | — | — | EP | claimed |
| WO-2009095569-A1 | POLYMER AQUEOUS DISPERSION WITH CORE/SKIN STRUCTURE, METHOD FOR MAKING SAME AND APPLICATION THEREOF IN COATINGS | CRAY VALLEY SA (FR) | 2009-08-06 | — | — | WO | claimed |
| US-6727314-B2 | BLEND OF POLYMER COMPRISING ACETOACETOXYETHYL (METH)ACRYLATE AND CASTOR OIL (METH)ACRYLATE COMONOMERS | BASF AG (DE) | 2004-04-27 | — | — | US | claimed |
| US-20030195297-A1 | Crosslinking systems for acrylic latex films | BASF AG (DE) | 2003-10-16 | — | — | US | claimed |
| WO-2003051990-A1 | ACRYLIC LATEX FILMS BASED ON CASTOR OIL (METH)ACRYLATE DERIVATIVES | BASF AG (DE) | 2003-06-26 | — | — | WO | claimed |
| EP-0710680-B1 | Aqueous polymer dispersion | BASF AG (DE) | 2003-03-19 | — | — | EP | claimed |
| EP-0421185-B1 | Polyacrylate copolymer, polyacrylate dispersion comprising polyacrylate copolymer, and process for preparing the same | HERCULES INC (US) | 1994-08-10 | — | — | EP | claimed |
| US-20250382506-A1 | SHELF STABLE ADHESIVE COMPOSITIONS | UNIV KANSAS (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250340760-A1 | ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES | UNIV KANSAS (US) | 2025-11-06 | — | — | US | disclosed |
| US-12351745-B2 | Single-component adhesive compositions | OHIO STATE INNOVATION FOUNDATION (US) | 2025-07-08 | — | — | US | disclosed |
| EP-4547771-A1 | SHELF STABLE ADHESIVE COMPOSITIONS | University of Kansas (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-4547770-A1 | ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES | University of Kansas (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025049242-A2 | BIO-BASED BINDER COMPOSITION FOR COATING APPLICATIONS | ARKEMA INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-6262144-B1 | MONOMERS ETHYLENICALLY UNSATURATED GROUP ARE POLYMERIZED BY FREE-RADICAL AQUEOUS EMULSION POLYMERIZATION TO GIVE A POLYMERIN DISPERSED DISTRIBUTION IN AQUEOUS MEDIUM, AND THEN FURTHER POLYMERIZING MONOMERS TO GIVE RANDOM COPOLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| US-6031038-A | A DISPERSED COPOLYMER WHICH IS OBTAINABLE BY FREE RADICAL AQUEOUS EMULSION POLYMERIZATION OF DIFFERENT MONOMER COMPOSITIONS IN TWO SUCCESSIVE STAGES; USE FOR COATING, ADHESIVE BONDING, SEALING, IMPREGNATING AND USE AS BINDERS | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-29 | — | — | US | disclosed |
| EP-0927208-A1 | PROCESS FOR PRODUCING AQUEOUS POLYMER DISPERSIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-07 | — | — | EP | disclosed |
| EP-0789724-B1 | AQUEOUS POLYMER DISPERSION | BASF AG (DE) | 1999-03-31 | — | — | EP | disclosed |
| US-5744540-A | POLYMERIZING FIRST MONOMERS IN FIRST STAGE BY FREE RADICAL EMULSION POLYMERIZATION TO CONVERT ATLEAST 90% POLYMER PRODUCT, THEN POLYMERIZING MIXTURE OF PRODUCT AND SECOND STAGE MONOMER BY FREE RADICAL EMULSION POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | disclosed |
| WO-1998010001-A1 | PROCESS FOR PRODUCING AQUEOUS POLYMER DISPERSIONS | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-12 | — | — | WO | disclosed |
| EP-0710680-A2 | Aqueous polymer dispersion | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340760-A1 | ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES | FN1, EPCAM, VCL | KMT2A 1654/4885RAB9A 2063/4885ALDH1A1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.